NASDAQ : ABSI
Absci Corporation — Financial statements
Healthcare · Biotechnology · United States
Last price 11.13 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.91B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Absci Corporation (ABSI) reported revenue of 1.56M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 1.56M | 2.80M | 4.53M | 5.72M | 5.75M | 4.78M |
| Cost of Revenue | 85.79M | 80.72M | 62.46M | 47.57M | 58.91M | 44.59M |
| Gross Profit | -84.23M | -77.92M | -57.92M | -41.85M | -53.16M | -39.80M |
| Selling, General & Admin | 35.28M | 35.06M | 36.17M | 37.83M | 40.55M | 27.88M |
| Operating Expenses | 46.37M | 46.80M | 49.56M | 51.83M | 53.59M | 34.53M |
| Operating Income | -130.60M | -124.72M | -107.49M | -93.68M | -106.75M | -74.34M |
| Interest Expense | -94.00K | -209.00K | -565.00K | -1.01M | -972.00K | -3.43M |
| Interest & Investment Income | 6.06M | 2.36M | ||||
| Other Non Operating Income (Expenses) | 5.22M | 5.41M | 6.42M | -31.79M | ||
| EBT Excluding Unusual Items | -125.48M | -119.52M | -101.64M | -88.63M | -105.36M | -109.56M |
| Merger & Restructuring Charges | -900.00K | |||||
| Impairment of Goodwill | -21.34M | |||||
| Asset Writedown | -700.00K | -700.00K | -1.40M | -500.00K | ||
| Other Unusual Items | 5.10M | 5.10M | 600.00K | |||
| Pretax Income | -121.08M | -115.11M | -103.04M | -110.47M | -105.36M | -109.86M |
| Income Tax Expense | 69.00K | 70.00K | 100.00K | -461.00K | -8.90M | |
| Net Income | -121.08M | -115.18M | -103.11M | -110.57M | -104.90M | -100.96M |
| Preferred Dividends & Other Adjustments | 2.28M | |||||
| Net Income to Common | -121.08M | -115.18M | -103.11M | -110.57M | -104.90M | -103.24M |
| Shares Outstanding (Basic) | 151.37M | 136.78M | 110.24M | 92.03M | 90.85M | 49.69M |
| Shares Outstanding (Diluted) | 151.37M | 136.78M | 110.24M | 92.03M | 90.85M | 49.69M |
| EPS (Basic) | -0.80 | -0.84 | -0.94 | -1.20 | -1.15 | -2.08 |
| EPS (Diluted) | -0.80 | -0.84 | -0.94 | -1.20 | -1.15 | -2.08 |
| Free Cash Flow | -108.97M | -94.03M | -72.81M | -65.50M | -97.51M | -98.64M |
| Free Cash Flow Per Share | -0.72 | -0.69 | -0.66 | -0.71 | -1.07 | -1.99 |
| Operating Margin | -8,366.43% | -4,454.21% | -2,370.71% | -1,638.34% | -1,857.49% | -1,554.54% |
| Profit Margin | -7,756.37% | -4,113.68% | -2,274.06% | -1,933.65% | -1,825.37% | -2,159.01% |
| Free Cash Flow Margin | -6,981.04% | -3,358.29% | -1,605.78% | -1,145.43% | -1,696.78% | -2,062.84% |
| EBITDA | -119.51M | -112.98M | -94.10M | -79.68M | -93.71M | -67.68M |
| D&A For EBITDA | 11.09M | 11.74M | 13.39M | 14.00M | 13.04M | 6.65M |
| EBIT | -130.60M | -124.72M | -107.49M | -93.68M | -106.75M | -74.34M |
| Revenue as Reported | 5.72M | 5.75M | 4.78M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 107.86M | 20.02M | 41.21M | 72.36M | 59.95M | 252.57M |
| Short-Term Investments | 93.28M | 124.27M | 71.21M | 25.30M | 104.48M | |
| Cash & Short-Term Investments | 201.14M | 144.29M | 112.42M | 97.66M | 164.43M | 252.57M |
| Receivables | 2.19M | 1.55M | 1.43M | |||
| Prepaid Expenses | 7.12M | 5.18M | 4.76M | 4.24M | 5.86M | 8.57M |
| Restricted Cash | 15.95M | 16.19M | 15.02M | 10.51M | ||
| Other Current Assets | 100.00K | 700.00K | 300.00K | |||
| Total Current Assets | 208.27M | 149.57M | 133.83M | 120.58M | 186.86M | 273.08M |
| Property, Plant & Equipment | 19.16M | 23.77M | 33.13M | 45.82M | 58.04M | 58.65M |
| Goodwill | 21.34M | 21.34M | ||||
| Other Intangible Assets | 40.05M | 41.51M | 44.88M | 48.25M | 51.62M | 54.99M |
| Other Long-Term Assets | 1.44M | 1.44M | 1.76M | 2.65M | 3.15M | 18.14M |
| Total Assets | 268.92M | 216.30M | 213.61M | 217.30M | 321.01M | 426.19M |
| Accounts Payable | 7.16M | 2.76M | 2.95M | 1.50M | 2.41M | 8.38M |
| Accrued Expenses | 9.10M | 16.59M | 7.50M | 6.55M | 7.73M | 17.43M |
| Current Portion of Long-Term Debt | 150.00K | 873.00K | 2.73M | 3.26M | 2.95M | 2.40M |
| Current Portion of Leases | 2.04M | 1.80M | 1.61M | 2.32M | 3.99M | 4.29M |
| Current Unearned Revenue | 1.15M | 739.00K | 1.12M | 3.17M | 445.00K | 1.35M |
| Other Current Liabilities | 12.75M | 12.75M | 12.75M | |||
| Total Current Liabilities | 19.60M | 22.77M | 28.66M | 29.56M | 30.27M | 33.86M |
| Long-Term Debt | 1.26M | 4.66M | 7.98M | 1.12M | ||
| Long-Term Leases | 1.64M | 2.62M | 4.43M | 5.64M | 8.07M | 12.20M |
| Long-Term Unearned Revenue | 240.00K | 436.00K | 966.00K | |||
| Long-Term Deferred Tax Liabilities | 238.00K | 743.00K | ||||
| Other Long-Term Liabilities | 1.31M | 1.02M | 133.00K | 295.00K | 35.00K | 12.16M |
| Total Liabilities | 22.79M | 26.85M | 34.48M | 41.12M | 46.59M | 60.09M |
| Common Stock | 17.00K | 15.00K | 12.00K | 9.00K | 9.00K | 9.00K |
| Additional Paid-In Capital | 933.56M | 813.63M | 688.73M | 582.70M | 570.45M | 557.14M |
| Retained Earnings | -687.59M | -624.78M | -509.60M | -406.50M | -295.93M | -191.03M |
| Comprehensive Income & Other | 150.00K | 591.00K | -4.00K | -37.00K | -120.00K | -13.00K |
| Total Common Equity | 246.13M | 189.45M | 179.13M | 176.18M | 274.41M | 366.11M |
| Shareholders' Equity | 246.13M | 189.45M | 179.13M | 176.18M | 274.41M | 366.11M |
| Total Liabilities & Equity | 268.92M | 216.30M | 213.61M | 217.30M | 321.01M | 426.19M |
| Total Debt | 3.83M | 5.30M | 10.03M | 15.88M | 22.98M | 20.01M |
| Net Cash (Debt) | 197.31M | 138.99M | 102.40M | 81.78M | 141.45M | 232.56M |
| Net Cash Per Share | 1.30 | 1.02 | 0.93 | 0.89 | 1.56 | 4.68 |
| Filing Date Shares Outstanding | 171.61M | 153.02M | 127.33M | 112.78M | 92.32M | 92.77M |
| Total Common Shares Outstanding | 171.56M | 151.52M | 115.36M | 93.09M | 92.41M | 92.65M |
| Working Capital | 188.67M | 126.81M | 105.17M | 91.02M | 156.59M | 239.22M |
| Book Value Per Share | 1.43 | 1.25 | 1.55 | 1.89 | 2.97 | 3.95 |
| Tangible Book Value | 206.08M | 147.94M | 134.25M | 127.92M | 201.46M | 289.78M |
| Tangible Book Value Per Share | 1.20 | 0.98 | 1.16 | 1.37 | 2.18 | 3.13 |
| Machinery | 29.30M | 33.68M | 38.10M | 40.48M | 32.58M | |
| Construction In Progress | 293.00K | 933.00K | ||||
| Leasehold Improvements | 27.08M | 27.06M | 27.05M | 26.86M | 24.67M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -121.08M | -115.18M | -103.11M | -110.57M | -104.90M | -100.96M |
| Depreciation & Amortization | 11.09M | 11.74M | 13.39M | 14.00M | 13.04M | 6.65M |
| Asset Writedown & Restructuring Costs | 21.34M | |||||
| Loss (Gain) From Sale of Investments | -1.92M | -2.54M | -3.74M | -2.67M | -688.00K | |
| Stock-Based Compensation | 18.28M | 18.32M | 19.45M | 11.42M | 12.54M | 10.61M |
| Other Operating Activities | -6.05M | -5.68M | 1.97M | 334.00K | 216.00K | 26.25M |
| Change in Accounts Receivable | 700.00K | 2.24M | -666.00K | -148.00K | 230.00K | |
| Change in Accounts Payable | -5.30M | 1.09M | 1.73M | -786.00K | -533.00K | 1.57M |
| Change in Unearned Revenue | 439.00K | 59.00K | -3.02M | 3.69M | -907.00K | -1.28M |
| Change in Other Net Operating Assets | -4.23M | -730.00K | -1.31M | -726.00K | 48.00K | -3.67M |
| Operating Cash Flow | -108.08M | -92.92M | -72.40M | -64.64M | -81.34M | -60.60M |
| Capital Expenditures | -890.00K | -1.11M | -404.00K | -860.00K | -16.18M | -38.05M |
| Sale of Property, Plant & Equipment | 175.00K | 1.31M | 939.00K | 254.00K | 133.00K | |
| Cash Acquisitions | -8.00M | -28.13M | ||||
| Investment in Securities | -12.01M | -50.37M | -42.11M | 82.55M | -103.59M | -1.20M |
| Other Investing Activities | 650.00K | |||||
| Investing Cash Flow | -12.72M | -50.16M | -41.58M | 81.94M | -126.98M | -67.38M |
| Short-Term Debt Issued | 125.00M | |||||
| Long-Term Debt Issued | 12.03M | |||||
| Total Debt Issued | 12.03M | 125.00M | ||||
| Long-Term Debt Repaid | -3.20M | -4.03M | -5.34M | -7.45M | -4.15M | |
| Net Debt Issued (Repaid) | -2.00M | -3.20M | -4.03M | -5.34M | 4.58M | 120.85M |
| Issuance of Common Stock | 180.16M | 112.86M | 87.02M | 862.00K | 656.00K | 230.30M |
| Other Financing Activities | -3.71M | -3.71M | -465.00K | -19.90M | ||
| Financing Cash Flow | 174.44M | 105.95M | 82.53M | -4.48M | 5.24M | 336.19M |
| Net Cash Flow | 53.63M | -37.14M | -31.45M | 12.82M | -203.08M | 208.22M |
| Free Cash Flow | -108.97M | -94.03M | -72.81M | -65.50M | -97.51M | -98.64M |
| Free Cash Flow Margin | -6,981.04% | -3,358.29% | -1,605.78% | -1,145.43% | -1,696.78% | -2,062.84% |
| Free Cash Flow Per Share | -0.72 | -0.69 | -0.66 | -0.71 | -1.07 | -1.99 |
| Levered Free Cash Flow | -50.59M | -37.20M | -33.23M | -34.43M | -63.56M | -65.68M |
| Unlevered Free Cash Flow | -50.53M | -37.06M | -32.88M | -33.80M | -62.95M | -63.53M |
| Cash Interest Paid | 178.00K | 178.00K | 561.00K | 970.00K | 895.00K | 652.00K |
| Change in Working Capital | -8.40M | 423.00K | -368.00K | 1.52M | -1.54M | -3.15M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.91B | 524.80M | 300.92M | 390.34M | 194.03M | 759.25M |
| Enterprise Value | 1.71B | 378.54M | 185.84M | 294.61M | 34.86M | 501.70M |
| Last Close Price | 11.13 | 3.49 | 2.62 | 4.20 | 2.10 | 8.20 |
| PS Ratio | 1,223.62 | 187.43 | 66.37 | 68.27 | 33.76 | 158.77 |
| PB Ratio | 7.76 | 2.77 | 1.68 | 2.22 | 0.71 | 2.07 |
| P/TBV Ratio | 9.27 | 3.55 | 2.24 | 3.05 | 0.96 | 2.62 |
| EV/Sales Ratio | 1,097.21 | 135.19 | 40.99 | 51.52 | 6.07 | 104.92 |
| Debt / Equity Ratio | 0.02 | 0.03 | 0.06 | 0.09 | 0.08 | 0.06 |
| Net Debt / Equity Ratio | -0.80 | -0.73 | -0.57 | -0.46 | -0.52 | -0.64 |
| Net Debt / EBITDA Ratio | 1.65 | 1.23 | 1.09 | 1.03 | 1.51 | 3.44 |
| Net Debt / FCF Ratio | 1.81 | 1.48 | 1.41 | 1.25 | 1.45 | 2.36 |
| Asset Turnover | 0.01 | 0.01 | 0.02 | 0.02 | 0.01 | 0.02 |
| Quick Ratio | 10.26 | 6.34 | 3.92 | 3.38 | 5.48 | 7.50 |
| Current Ratio | 10.63 | 6.57 | 4.67 | 4.08 | 6.17 | 8.06 |
| Return on Equity (ROE) | -57.72% | -62.50% | -58.04% | -49.08% | -32.76% | -46.62% |
| Return on Assets (ROA) | -34.09% | -36.26% | -31.18% | -21.75% | -17.86% | -18.05% |
| Return on Capital Employed (ROCE) | -52.40% | -64.40% | -58.10% | -49.90% | -36.70% | -18.90% |
| Earnings Yield | -7.19% | -21.95% | -34.26% | -28.32% | -54.07% | -13.30% |
| FCF Yield | -5.71% | -17.92% | -24.19% | -16.78% | -50.26% | -12.99% |
| Buyback Yield / Dilution | -25.96% | -24.07% | -19.79% | -1.30% | -82.84% | -220.66% |